发明授权
US08202884B2 Treatment of type 2 diabetes 有权
2型糖尿病的治疗

Treatment of type 2 diabetes
摘要:
The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the treatment of diabetic patients.
公开/授权文献
信息查询
0/0